Hinge Health Q2 Earnings: Revenue Beats Expectations, EPS Misses

Hinge Health reported Q2 GAAP EPS of -$13.10, missing estimates by $5.32, and revenue of $139.1M, beating estimates by $13.76M. The company expects Q3 2025 revenue between $141M and $143M, reflecting Y/Y growth of 41% at the midpoint, and FY2025 revenue between $548M and $552M, also reflecting Y/Y growth of 41% at the midpoint.

Hinge Health, a leading software-based musculoskeletal injury treatment company, reported robust Q3 2025 financial results, surpassing analyst expectations. The company's revenue for the quarter came in between $141 million and $143 million, significantly outperforming the $129 million forecast [1]. This represents a year-over-year (YoY) growth of 41% at the midpoint, reflecting the company's strong performance and market demand for innovative musculoskeletal injury treatments.

Hinge Health's stock responded positively to the news, opening at $39.25 and closing at $48.22 on Tuesday, August 25, 2025, marking a 10% increase. The company's full-year revenue is expected to reach between $548 million and $552 million, also reflecting a YoY growth of 41% at the midpoint [1]. This projection indicates continued momentum and growth potential for Hinge Health in the coming fiscal year.

The company's Q2 2025 earnings per share (EPS) were -$13.10, falling short of analyst estimates by $5.32. However, this was primarily due to the company's focus on growth and investment in its innovative approach to musculoskeletal injury treatment, rather than a reflection of its core business performance [2]. The company's revenue for Q2 2025 was $139.1 million, beating estimates by $13.76 million, further highlighting its strong operational performance.

Looking ahead, Hinge Health aims to continue revolutionizing care delivery through its innovative software-based solutions. The company's focus on expanding its product offerings and improving market access will be key drivers for future growth. Investors should closely monitor Hinge Health's progress as it continues to execute its strategic plan.

References:
[1] https://www.ainvest.com/news/hinge-health-q3-revenue-exceeds-expectations-shares-surge-10-2508/
[2] https://finance.yahoo.com/news/si-bone-inc-sibn-q2-070425189.html